Tesamorelin
Tesamorelin is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010.
Online Inquiry
| CAT# | HB00122 |
| CAS | 218949-48-5 / 901758-09-6 |
| Synonyms/Alias | Tesamorelin |
| M.F/Formula | C211H366N72O67S1 |
| M.W/Mr. | 5135.89 |
| Sequence | Three Letter Code: Asp-Arg-Val-Tyr-Val-His-Pro-Phe |
| Biological Activity | Tesamorelin is a synthetic growth hormone releasing hormone analogue used in the treatment of visceral adiposity in human immunodeficiency virus (HIV) infected patients with lipodystrophy. |
| Storage | Desiccate at -20°C |
Shipping Condition | Room temperature in continental US; may vary elsewhere. |
Write a review
Ask a question
My Review for Tesamorelin
Required fields are marked with *
×
Ask a Question for Tesamorelin
Required fields are marked with *
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
